Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
FSLR enters its October 27 earnings with Goldman Sachs trimming its price target this morning, short interest still near a cycle high, and analyst consensus pointing sharply above current levels despite a month-long string of target reductions.
The Street's direction of travel is unmistakably lower, even as the underlying view stays bullish. Goldman's Brian Lee, filing this morning, cut his target to $272 from $310 while holding a Buy rating. That follows Piper Sandler trimming to $251 last week and GLJ Research cutting to $250 from $315 on September 22. The pattern is consistent: firms maintaining positive ratings but walking back the price they are willing to pay. The mean analyst target now sits at $274, still 52% above the current price of $180, a gap that ranks in the 93rd percentile of analyst recommendation divergence across the ORTEX universe. That score flags unusually strong Street conviction relative to where the stock is trading. The bull case rests on First Solar's China-free supply chain, a $13.6 billion backlog, and policy tailwinds from Section 232 and UFLPA enforcement. Bears point to slowing downstream project starts, flat-to-declining pricing, and the risk that 45X credits get passed through to customers rather than held as margin.
Valuation gives some context for the hesitation. The trailing PE has compressed to 8.2, down roughly 1.75 points over the past month, with the EV/EBITDA multiple also easing to 5.5. Both sit at low absolute levels, which the factor score system captures: FSLR ranks in the 98th percentile on EV/EBIT relative to its universe, a strong value signal. EPS surprise history is also solid, in the 75th percentile, though forward earnings momentum is weak: the 90-day EPS revision score sits in the 29th percentile, meaning analysts have been cutting estimates more than raising them heading into the print.
Short positioning has stabilised near its recent high. Short interest closed at 10.6% of free float, effectively flat for the week after a brief dip mid-session Wednesday. The monthly build is the more notable move: from roughly 9.4% in early September to where it is now, a 15% increase in borrowed shares. The ORTEX short score has nudged up to 57.9, a new high for the recent range and above the 56.4 level that the previous note flagged as elevated. Critically, the borrow market gives bears no structural constraint. Availability runs at 465%, meaning for every share currently lent out there are more than four still available to borrow, and the cost to borrow is just 0.54%, up about 5% on the week but still negligible in absolute terms. No squeeze pressure is building in the lending pool.
Options positioning has drifted slightly more defensive but without anything dramatic. The put/call ratio sits at 0.77, just below one standard deviation above its 20-day average of 0.74. That is a measured rather than extreme reading, consistent with investors buying some downside protection into the earnings date without aggressive directional conviction. The 52-week high on the PCR is 0.89, still well above current levels. One institutional flow worth noting: Capital Research and Management added 3.7 million shares in the most recent reported period, a substantial increase that made it a top-five holder. BlackRock, reporting as of September 30, added roughly 208,000 shares to bring its stake to 13%. The activist register carries a Schedule 13D/A from Farhad Ebrahimi, last filed in March 2025, with a reported 4.95% stake. Stakes on that register are as last disclosed around the 5% threshold, and a holder can fall below 5% without a further filing.
Wikipedia attention for First Solar is running well below its own 90-day norm, with a z-score of negative 1.6 as of late September, a signal of reduced retail engagement at a moment when institutional bears have been adding. With earnings due in 19 days, the setup worth tracking is whether the continuing target cuts from the Street narrow the gap between analyst expectations and where shorts are positioned, or whether the Q3 print gives bears the volume and pricing data they have been anticipating.
See the live data behind this article on ORTEX.
Open FSLR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.